MHRA Drug & Device Safety Alerts
Drug safety updates, medicines recalls, device safety information and field safety notices published by the Medicines and Healthcare products Regulatory Agency. Source: MHRA alerts and recalls on GOV.UK.
Clopixol Conc Injection (500mg/ml) - cracked ampoules
Auxiliary common gas outlet (ACGO) for anaesthetic machine - no fresh gas flow to patient with wrong setting
Xigris 5 mg and 20 mg recall due to risk/benefit concerns
Nurofen Plus tablets containing rogue blister strips in additional 2 cartons
Canesten Pessary - 2 batches have wrong patient information leaflet
Needle-free intravenous connectors - incompatibility and risk of infection
Plum A+ infusion pumps - potential failure
Sprint Fidelis implantable cardioverter defibrillator (ICD) lead - risk of inappropriate shocks
Ligasure blunt tip laparoscopic sealer/divider - potential risk of serious thermal burns
All types, makes and models of breast implants - potential increased risk of anaplastic large cell lymphoma (ALCL)
Recall of Avandia 4mg, 8mg, Avandamet 1mg/500mg, 2mg/500mg, 2mg/1000mg, 4mg/1000mg
Silicone gel filled breast implants - advice on clinical management of women with implants
Intravenous (IV) extension sets with multiple ports - risk of backtracking
Novabel® dermal filler - practitioners should stop use and return all unused products
Fetal monitor/cardiotocograph (CTG) - adverse outcomes still reported
Aquarius haemofiltration machines - follow instructions carefully
All anaesthetic breathing systems, anaesthetic machines and anaesthetic ventilators - inadequate ventilation
All models and lot numbers of silicone gel filled breast implants - unapproved composition of silicone gel
Hansen-type coloured dialysis fluid line connectors - incorrectly configured
Intraocular lens (IOL) - hydrophilic acrylic - opacification
Devices used for endometrial ablation - clinicians should confirm patients have no evidence of uterine perforation or false passage
All types of bed mattresses - contamination through damaged mattresses or covers
Ultrasound transducer - review advice by the Advisory Committee on Dangerous Pathogens (ACDP)
Aquarius haemofiltration machine - manufacturer has updated their actions for software problems
Bioprosthetic heart valves - follow manufacturer's instructions to prepare implants before use
SynchroMed EL models 8626 and 8627 and SynchroMed II model 8637 implantable drug pumps - scan patients with these
Implantable cardioverter defibrillators (ICDs) - disable all high voltage shock therapies before you remove ICD
N’Vision® and InterStim iCon® used with InterStim implantable neurostimulator model 3023 for pelvic floor disorders neurostimulator programmers - error in programmer software
Implantable drug pumps for intrathecal therapy - risk of temporary or permanent neurological impairment
External pacemakers and temporary cardiac pacing leads - concerns that insecure systems still being used
Patient hoists and slings - ensure you follow manufacturer's instructions for use and that you carry out risk assessments
MiniCap peritoneal dialysis disconnect cap with povidone-iodine - monitor thyroid function in patients with small fill volumes
All cochlear implants - update on immunisation recommendations
Implantable cardioverter defibrillators (ICDs) - ensure you have updated software for models 3510 and 3510+ ICD programmers
Trilucent (soya bean oil filled) breast implants - update on actions from previous risks
Paracetamol Tablets 500mg - incorrect blister foil
Orgaran 750 anti-Xa units solution for injection – incorrect patient information leaflet
Amoxil Vials for injection 500mg and 1g, Augmentin Intravenous 600mg and 1.2g - cracks in vials used for packaging
TELIGEN implantable cardioverter defibrillators (ICD) and COGNIS cardiac resynchronisation therapy devices (CRT-D) - identify patients affected recently
All medical devices - ensure system is in place to distribute field safety notices (FSNs)
Ellipse™ VR/DR implantable cardioverter defibrillators (ICDs) - potential failure mode
Ecoflac infusion solutions: risk of air embolism
An article in MHRA's monthly Drug Safety Update bulletin.
Combination use of medicines from different classes of renin-angiotensin system blocking agents: risk of hyperkalaemia, hypotension, and impaired renal function—new warnings
An article in MHRA's monthly Drug Safety Update bulletin.
Codeine for analgesia: restricted use in children because of reports of morphine toxicity
An article in MHRA's monthly Drug Safety Update bulletin.
Drug Safety Update gains NHS Evidence accreditation
An article in MHRA's monthly Drug Safety Update bulletin.
St John’s wort: interaction with hormonal contraceptives, including implants
An article in MHRA's monthly Drug Safety Update bulletin.
Paraffin-based treatments: risk of fire hazard
An article in MHRA's monthly Drug Safety Update bulletin.
Dronedarone (Multaq▼): cardiovascular, hepatic and pulmonary adverse events – new restrictions and monitoring requirements
An article in MHRA's monthly Drug Safety Update bulletin.
Mycophenolate mofetil: pure red cell aplasia
An article in MHRA's monthly Drug Safety Update bulletin.
About this source
Read the chart values
| Alert type | Individual alerts |
|---|---|
| Drug Safety Update | 713 |
| Class 1 Medicines Recall | 6 |
| Class 2 Medicines Recall | 159 |
| Class 3 Medicines Recall | 68 |
| Class 4 Medicines Defect Information | 179 |
| Company-Led Medicines Recall | 35 |
| Device Safety Information | 21 |
| Medical Device Alert | 40 |
| National Patient Safety Alert | 11 |
| MHRA Safety Roundup | 16 |
| Unclassified | 253 |
The MHRA regulates medicines and medical devices in the UK and publishes safety communications on GOV.UK in two streams: the monthly Drug Safety Update bulletin, and Alerts and recalls for drugs and medical devices. This page holds 2,267 of those publications, issued between October 2009 and July 2026.
MHRA classes a medicines recall by the hazard the defect presents: Class 1 life-threatening or serious, Class 2 could cause illness or mistreatment, Class 3 unlikely to cause harm, and Class 4 a caution in use rather than a recall, with the product staying available. A device notice is published as Device Safety Information, or, until 2021, as a Medical Device Alert.
What is not here. We hold each publication's title, type, date and link, not its text: read the alert on GOV.UK for the affected products and the actions MHRA asks for. An alert names a medicine or device and a clinical audience, not an organisation, so no alert on this page is linked to an NHS trust or other responsible body. The weekly “Field Safety Notices” pages are MHRA's own index of the notices manufacturers issued that week, not single alerts, and are counted separately above.